摘要
目的探讨马来酸桂哌齐特联合刺五加治疗腔隙性脑梗死的临床效果及安全性。方法将80例腔隙性脑梗死患者随机分为观察组和对照组,对照组40例给予常规西医综合治疗措施,观察组40例在对照组治疗基础上给予马来酸桂哌齐特联合刺五加治疗,评估2组治疗效果。结果治疗后2周及治疗后1个月观察组患者神经功能缺损程度评分均低于对照组(P<0.05)。观察组总有效率为97.5%,对照组为80.0%,2组比较差异具有统计学意义(P<0.05)。2组治疗过程中均无明显的不良反应产生。结论马来酸桂哌齐特联合刺五加治疗腔隙性脑梗死的临床疗效确切,且安全性高。
Objective To investigate the efficacy and safety of cinepazide maleate combined with acanthopanax injection in the treatment of lacunar infarction. Methods Eighty injection patients with lacunar infarction were randomly divided into observation group and control group, with 40 patients in each group. All patients were given the conventional Western medicine treatment. The observation group was additionally treated with cinepazide maleate injection and acanthopanax injection. Therapeutic efficacy was evaluated in both groups. Results The neurologic impairment scores in observation group were lower than those in control group 2 weeks and 1 month after treatment（P〈0.05）. In addition, the total effective rate in observation group was higher than that in control group（97.5% vs 80.0%, P〈0.05）. No significant adverse reactions were found in both groups. Conclusion The combined treatment with cinepazide maleate injection and acanthopanax injection is effective and safe for lacunar infarction.
出处
《实用临床医学（江西）》
CAS
2013年第2期27-28,40,共3页
Practical Clinical Medicine
关键词
马来酸桂哌齐特
刺五加
腔隙性脑梗死
cinepazide maleate injection
acanthopanax
lacunar infarction
